Management of Hypertension and Anti-Hypertensive Drug Profile in End-Stage-Renal-Disease Patients Undergoing Maintenance Hemodialysis  

Authors: Zujajah Gull, Zahra Anwar, Bushra Ali Sherazi

Institute of Pharmacy, Lahore College for Women University.

Volume 22 | Issue 3

Published: October 23, 2026

Abstract

Hypertension is common in patients of end stage renal disease treated with hemodialysis. Objective: To observe management of hypertension and antihypertensive drug profile in end stage renal disease (ESRD) patients undergoing hemodialysis. Methods: An observational study was conducted for 2 months (August 2015) - September 2015) in different hospitals of Lahore. Population of 50 dialysis ward patients was randomly selected during this period and study was performed by filling data collection forms from patients. Collected data was analyzed and results were presented in the form of graphs and tables. Results: Of the total patients, 56% were male and 44% were female. Hypertension (62%) and diabetes (20%) are leading cause of CKD. 76% patients were on low sodium diet and only 40% do exercise to control their blood pressure. 78% patients use calcium channel blockers alone or in combination with alpha or beta blockers as antihypertensive agents. Conclusion: Treatment with agents that lower blood pressure should routinely be considered for individuals undergoing dialysis to reduce the very high cardiovascular morbidity and mortality rate in this population. At the same time educating the patients regarding restricting the dietary salt or fluid intake will enable them to control their blood pressure and improve their quality of life.

Keywords: hypertension, ESRD, CKD, antihypertensive drug profile.

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF